Ebumab Holding ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  8.8% 2.3% 5.1% 6.4% 4.1%  
Credit score (0-100)  29 65 42 36 48  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.1 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  881 785 0 0 0  
Gross profit  851 392 -44.9 -56.7 -22.7  
EBITDA  9.8 -359 -46.1 -56.7 -23.3  
EBIT  9.8 -359 -46.1 -56.7 -23.3  
Pre-tax profit (PTP)  -3.0 -337.3 110.5 128.7 219.6  
Net earnings  -3.0 -337.3 163.3 100.1 171.3  
Pre-tax profit without non-rec. items  -3.0 -337 111 129 219  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  47.0 5,210 5,373 5,473 5,644  
Interest-bearing liabilities  7,467 3,592 1,133 1.1 0.0  
Balance sheet total (assets)  7,795 10,891 6,541 5,579 5,745  

Net Debt  7,408 1,236 -906 -523 -471  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  881 785 0 0 0  
Net sales growth  0.0% -10.9% -100.0% 0.0% 0.0%  
Gross profit  851 392 -44.9 -56.7 -22.7  
Gross profit growth  0.0% -53.9% 0.0% -26.2% 59.9%  
Employees  1 1 0 0 0  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,795 10,891 6,541 5,579 5,745  
Balance sheet change%  0.0% 39.7% -39.9% -14.7% 3.0%  
Added value  9.8 -359.0 -46.1 -56.7 -23.3  
Added value %  1.1% -45.7% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 -2.0 0.0 0.0  
EBIT trend  1.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  1.1% -45.7% 0.0% 0.0% 0.0%  
EBIT %  1.1% -45.7% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  1.2% -91.6% 102.6% 100.0% 102.5%  
Net Earnings %  -0.3% -42.9% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  -0.3% -42.9% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  -0.3% -42.9% 0.0% 0.0% 0.0%  
ROA %  2.9% 0.2% 2.6% 2.3% 3.9%  
ROI %  3.0% 0.2% 3.0% 2.3% 3.9%  
ROE %  -6.3% -12.8% 3.1% 1.8% 3.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  96.4% 47.8% 82.1% 98.1% 98.2%  
Relative indebtedness %  879.2% 723.4% 0.0% 0.0% 0.0%  
Relative net indebtedness %  872.5% 423.5% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  75,373.4% -344.4% 1,967.0% 922.4% 2,020.5%  
Gearing %  15,874.9% 68.9% 21.1% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  6.1% 6.5% 5.0% 1.5% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  27.6 3.6 183.7 51.4 55.7  
Current Ratio  27.6 3.6 183.7 51.4 55.7  
Cash and cash equivalent  59.0 2,355.7 2,039.3 523.9 471.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  878.9% 948.4% 0.0% 0.0% 0.0%  
Net working capital  7,464.5 5,358.6 6,416.0 5,343.1 5,514.4  
Net working capital %  847.0% 682.3% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  881 785 0 0 0  
Added value / employee  10 -359 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  10 -359 0 0 0  
EBIT / employee  10 -359 0 0 0  
Net earnings / employee  -3 -337 0 0 0